How much funding has Genome Compiler raised?

Genome Compiler has raised $6.0M in total funding, most recently a Seed round.

Who are Genome Compiler's investors?

Genome Compiler's investors include Autodesk, LionBird.

When was Genome Compiler founded?

Genome Compiler was founded in 2011.

Where is Genome Compiler headquartered?

Genome Compiler is headquartered in Tel Aviv, Israel.

What industry is Genome Compiler in?

Genome Compiler operates in Biotech, Marketplace, Synthetic Biology, Developer Tools, SaaS.

How many employees does Genome Compiler have?

Genome Compiler has 1-10 employees.

Genome Compiler

Closed

Tel Aviv, Israel · Founded 2011 · $6.0M raised

Headquarters: Tel Aviv
Employees: 1–10
Founded: 2011
Business Model: B2B

Website: genomecompiler.com
Total Funding: $6.0M
Last Round: $6.0M SeedApr 2016
Rounds: 1

About

Genome Compiler provided a SaaS-based computer-aided design (CAD) and collaboration platform for the synthetic biology industry, enabling scientists to design, simulate, and order custom DNA programs that could be shipped as physical DNA for transforming living organisms. The platform also offered access to DNA synthesis providers, bioinformatics tools, and genetic repositories. Founded in Israel in 2011, the company was acquired by Twist Bioscience in April 2016.

Summary

Genome Compiler is a Biotech company based in Tel Aviv, Israel, founded in 2011. It has raised $6.0M in total across 1 round, most recently a $6.0M Seed round in Apr 2016. Investors include Autodesk and LionBird.